CAS NO: | 4199-10-4 |
包装 | 价格(元) |
10mM (in 1mL H2O) | 电议 |
100mg | 电议 |
Physical Appearance | A solid |
Storage | Store at RT |
M.Wt | 295.81 |
Cas No. | 4199-10-4 |
Formula | C16H21NO2·HCl |
Solubility | ≥15.65 mg/mL in H2O; ≥2.9 mg/mL in EtOH with gentle warming and ultrasonic; ≥57.5 mg/mL in DMSO |
Chemical Name | (S)-1-(isopropylamino)-3-(naphthalen-1-yloxy)propan-2-ol hydrochloride |
Canonical SMILES | O[C@H](COC1=CC=CC2=CC=CC=C12)CNC(C)C.Cl |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
(S)-(-)-Propranolol hydrochloride is a more active enantiomer of propranolol, acting as a β-adrenoceptor antagonist with logKdvalues being -8.16, -9.08 and -6.93 for human β1-, β2- and β3-adrenoceptors stably expressed in Chinese hamster ovary cells, respectively. β-Adrenoceptor antagonists are one of the most commonly used classes of drugs in cardiovascular medicine (hypertension, ischemic heart disease and heart failure) as well as in the management of anxiety, migraine and glaucoma. In addition, (S)-(-)-propranolol hydrochloride is also a non-specific serotonin receptor antagonist, capable of inhibiting the behavioral responses to increased brain 5-hydroxytryptamine (5-HT).
References:
1. Baker JG. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. British Journal of Pharmacology, 2005, 144(3): 317-322.
2. Costain DW, Green AR. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine. British Journal of Pharmacology, 1978, 64(2): 193-200.
3. Barrett AM, Cullum VA. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. British Journal of Pharmacology, 1968, 34(1): 43-55.
Animal experiment:[3] | |
Animal models | Cats anaesthetized with halothane |
Dosage form | From 0.05 mg/kg to the dose at which the arrhythmia to adrenaline was abolished Given intravenously |
Applications | Both (S)-(-)-propranolol and (S)-(+)-propranolol were capable of preventing adrenaline-induced cardiac arrhythmias in cats anaesthetized with halothane, but the mean dose of (S)- (-)-propranolol was 0.09 ± 0.02 mg/kg whereas that of (S)-(+)-propranolol was 4.2 ± 1.2 mg/kg. |
Note | The technical data provided above is for reference only. |
References: 1. Baker JG. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. British Journal of Pharmacology, 2005, 144(3): 317-322. 2. Costain DW, Green AR. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine. British Journal of Pharmacology, 1978, 64(2): 193-200. 3. Barrett AM, Cullum VA. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. British Journal of Pharmacology, 1968, 34(1): 43-55. |